Quantiferon-CMV

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Quantiferon-CMV trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT04030676

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoM…

France196 participantsStarted 2019-07-17Updated 2025-04-29

Treatment: Biopsies, Blood samples

RecruitingNot Applicable

NCT06341543

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Context Cytomegalovirus (CMV) infection is a frequent and potentially severe event in solid organ transplant (SOT) recipients. Most of available treatment dis…

France288 participantsStarted 2024-09-24Updated 2024-10-01

Treatment: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the QF-CMV to the clinician in charge

All recent trials (11 shown)

CompletedNot Applicable

NCT07621835

Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in…

The goal of this observational study is to identify risk factors associated with the absence of CMV-specific cellular immune response in low-risk CMV-seropositi…

Spain236 participantsStarted 2019-01-01Updated 2026-06-02

TerminatedNot Applicable

NCT02064699

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®…

Cytomegalovirus (CMV) infection was observed in over 30% of organ recipients with high morbidity. Moreover, no prophylaxis, 75% R + D-transplanted, 55%, R + D +…

France75 participantsStarted 2013-05Updated 2025-08-01

Treatment:

Quantiferon-CMV

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

All recent trials (11 shown)

Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in…

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

All recent trials (11 shown)

Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in…

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®…

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Clinical Evaluation of the QuantiFERON CMV Assay

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients,…

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lun…

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients